Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
申请人:Fibrostatin, S.L.
公开号:US20160184274A1
公开(公告)日:2016-06-30
Methods of using inhibitors of Goodpasture Antigen Binding Protein for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition (EMT), treating an invasive tumor, and detecting EMT in a tissue are described.
The present invention provides compositions including anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7, and their use in treating cancer.